Insurers Defend $67M Antitrust Win Amid Mylan Appeal
Blue Cross Blue Shield of Massachusetts and three other insurers are fighting to keep a combined $67 million award in their long-running price-fixing suit against Mylan Pharmaceuticals and chemical companies Cambrex...To view the full article, register now.
Already a subscriber? Click here to view full article